Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery

Launched by AZIENDA USL REGGIO EMILIA - IRCCS · Jan 22, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how a special test called bioimpedance analysis (BIVA) can help healthcare providers assess patients before and after lung surgery, specifically for those with lung cancer. BIVA involves passing a mild electrical current through the body to measure things like hydration levels and muscle mass. This information can be valuable in predicting how well a patient might recover after surgery, especially since recovery can vary greatly among individuals. The study will also look at how these measurements relate to common post-surgery issues, such as heart rhythm problems or lung complications.

To participate in this trial, patients should be between the ages of 65 and 74 and scheduled for lung surgery due to a primary cancer diagnosis within the past year. However, patients with certain conditions, such as chronic heart rhythm issues or those who have had significant lung surgery before, will not be eligible. Participants can expect to have their body composition assessed before and after surgery, and the trial aims to gather important data that could improve care for future patients undergoing similar procedures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Patients undergoing pulmonary resection surgery for primary neoplasm within a one-year timeframe.
• Exclusion Criteria:
• • Patients with chronic atrial fibrillation (AF).
• • Patients who have previously undergone major pulmonary resection.
• • Patients with pacemakers or implantable devices, as the use of bioimpedance vector analysis (BIVA) may be contraindicated.